You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 5, Nov 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Continuous Antibiotic Prophylaxis and the Staphylococcal Carrier

ALVIN NOVACK, M.D.; HARRY A. FELDMAN, M.D.

Arch Intern Med. 1962;110(5):726-734.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

While general recognition of the emergence of antibiotic-resistant, coagulase-positive staphylococci in both hospitals1-4 and communities5,6 has led to extensive reinvestigation of this organism, our knowledge of its epidemiology in the nonhospital environment remains inadequate. The presence of resistant Staphylococcus aureus in the community has been related by some7,8 to recent hospitalization and treatment with antibiotics. A recent Australian study showed that 64% of S. aureus strains isolated from the purulent lesions of patients who were seen in doctors' offices were resistant to penicillin.9 Others,10-13 who have studied people who were receiving continuous prophylactic antibiotic medication, have reported that such individuals become carriers of resistant organisms more often than does the population at large.

In an effort to determine more accurately the relation between coagulase-positive staphylococci and non-hospital-centered persons, we have been conducting several long-term surveillance programs in different population groups. A preliminary report14 of . . . [Full Text PDF of this Article]


Author Affiliations

SYRACUSE, N.Y.

Formerly Fellow in Preventive Medicine and EIS Officer, Public Health Service, Department of Health, Education, and Welfare, Communicable Disease Center (Dr. Novack); Professor of Preventive Medicine (Dr. Feldman).; From the Department of Preventive Medicine, State University of New York, Upstate Medical Center.


Footnotes

With the assistance of Shirley Schaeffer.

Supported by Grant E-2943 from the National Institutes of Health, Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.